Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00430313
What this trial is testing

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

Who this might be right for
Liver CancerLiver Metastasis
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Not applicableStudy completedNCT00782886
What this trial is testing

Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer

Who this might be right for
Liver Cancer
Pathfinder Therapeutics 75
Early research (Phase 1)UnknownNCT05643417
What this trial is testing

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Who this might be right for
Metastatic Liver Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Large-scale testing (Phase 3)Looking for participantsNCT06007846
What this trial is testing

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Inova Health Care Services 12
Not applicableStudy completedNCT00976898
What this trial is testing

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma

Who this might be right for
Liver Cancer
Massachusetts General Hospital 83
Early research (Phase 1)Study completedNCT00093444
What this trial is testing

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Who this might be right for
Liver CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 30
Large-scale testing (Phase 3)UnknownNCT05701436
What this trial is testing

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Who this might be right for
Liver, Cancer of, Primary Resectable
Zhujiang Hospital 144
Early research (Phase 1)UnknownNCT05123209
What this trial is testing

Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors

Who this might be right for
Liver Cancer
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Testing effectiveness (Phase 2)UnknownNCT00471484
What this trial is testing

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
National Cancer Centre, Singapore 54
Not applicableStudy completedNCT01401907
What this trial is testing

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerMesothelioma+4 more
Massachusetts General Hospital 351
Not applicableUnknownNCT06278701
What this trial is testing

The Effect of Late-evening Snacks on Patients With Primary Hepatocellular Carcinoma After Hepatectomy

Who this might be right for
Liver Neoplasms
DU Yao 106
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Testing effectiveness (Phase 2)Study completedNCT02795429
What this trial is testing

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 89
Testing effectiveness (Phase 2)WithdrawnNCT02070419
What this trial is testing

TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaRecurrent Adult Primary Liver CancerStage I Adult Primary Liver Cancer+2 more
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00057382
What this trial is testing

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Tularik 750
Early research (Phase 1)Ended earlyNCT05427396
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Who this might be right for
Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 31
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Next Page